查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1627915

输液袋市场：未来预测（2025-2030）

IV Bags Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 141 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

输液袋市场预计将从 2025 年的 43.12 亿美元成长到 2030 年的 56.77 亿美元，复合年增长率为 5.66%。

静脉注射袋是一种装有液体、电解质、维生素、矿物质、葡萄糖溶液等的袋子，用于输送身体所需的液体和营养素。输液包的需求是由电解质耗尽、补水不足和营养不良等问题日益严重所驱动，这推动了对注入人体的液体营养素和替代品的需求。

此外，由于输液袋易于获取，正逐渐成为一种流行且优选的肠外给药替代品。一个输液包的成本约为1美元，这对市场贸易的扩张做出了巨大贡献。

此外，道路交通事故是全球造成残疾和死亡的主要原因之一，每年导致 5,000 万人受伤和 130 万人死亡。根据世界卫生组织 (WHO) 的数据，全球整体四分之一的死亡与步行或骑自行车有关。因此，手术和事故的增加将需要输液，预计这将刺激市场扩张。

输液袋市场驱动因素

  • 慢性病的流行正在推动市场需求。

在预计预测期内，慢性病盛行率上升、手术和道路事故数量增加以及老年人口成长等因素将推动市场成长。例如，美国国立卫生研究院2022年7月表示，在北美和欧洲等西方地区，截至2022年，约有20%的个体患有胃食道逆流（GERD）。此外，美国GERD 的发生率从 18.1% 上升至 27.8%。

此外，《2023 年癌症现实与数据》报告的资讯预测，2023 年美国将有 297,790 名女性死于乳癌，高于 2022 年的 287,850 例。此外，根据同一资讯来源，预计 2023 年美国约有 55,720 名女性被诊断出患有非侵入性（原位）乳癌，而 2022 年这一数字为 51,400 例。由于癌症治疗会对身体造成影响，剥夺身体的营养，并导致溃疡、胃肠功能障碍和身体阻塞，因此对输液袋的需求预计会增加。接受肠外营养的患者的需求不断增长，推动了市场扩张。

输液袋市场的地理前景

  • 预计在预测期内北美仍将是市场的主要股东。

从地理上看，输液袋市场分为北美洲、南美洲、欧洲、中东和非洲以及亚太地区。

在预测期内，预计北美将占据相当大的市场占有率，这得益于主要区域经济体慢性病患病率的上升、医疗保健基础设施的完善以及外科手术和医院就诊数量的增加。美国医院协会称，2022年，美国住院人数达34,011,386人次，而医院住院人数为6,129人次。

同样，外科手术的流行也推动了市场需求。例如，根据美国整形外科医师协会的数据，2023 年报告的手术总数为 1,575,244 例，比 2022 年报告的数字增加了 5%。此外，亚伯达省政府提供的资料显示，2022年手术总数为292,500次，比前一年增加了13,900次。

为什么要购买这份报告？

  • 深刻分析：获得深入的市场洞察，涵盖主要地区和新兴地区，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他子区隔。
  • 竞争格局：了解全球主要企业所采用的策略策略，并了解正确策略带来的潜在市场渗透率。
  • 市场驱动因素和未来趋势：探索动态因素和关键市场趋势以及它们将如何影响市场的未来发展。
  • 可行的建议：利用洞察力进行策略决策，在动态环境中开闢新的业务流和收益。
  • 适合广泛的用户：对于新兴企业、研究机构、顾问公司、中小企业和大型企业来说，它都是实用且具有成本效益的。

它有什么用途？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

分析范围

  • 历史资料与预测（2022-2030）
  • 成长机会、挑战、供应链前景、法规结构、顾客行为、趋势分析
  • 竞争对手定位、策略与市场占有率分析
  • 按部门和地区（国家）分類的收益成长和预测分析
  • 公司简介（策略、产品、财务资讯、主要趋势等）

输液袋市场细分为：

按类型

  • PVC
  • PP
  • PE

按容量

  • 少于100毫升
  • 100～250ml
  • 250～500ml
  • 500～1000ml
  • 1000毫升以上

按腔室类型

  • 单室
  • 多室

按最终用户

  • 血库
  • 医院
  • 门诊服务

按地区

  • 北美洲
  • 美国
  • 加拿大
  • 墨西哥
  • 南美洲
  • 巴西
  • 阿根廷
  • 其他的
  • 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 其他的
  • 中东和非洲
  • 沙乌地阿拉伯
  • 以色列
  • 其他的
  • 亚太地区
  • 中国
  • 日本
  • 韩国
  • 印度
  • 其他的

目录

第 1 章 简介

  • 市场概况
  • 市场定义
  • 分析范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第 2 章 分析方法

  • 分析设计
  • 分析过程

第三章执行摘要

  • 主要发现
  • CXO观点

第四章 市场动态

  • 市场驱动因素
  • 市场限制
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章 输液袋市场类型

  • 介绍
  • PVC
  • PP
  • PE

第六章 输液袋市场规模

  • 介绍
  • 少于100毫升
  • 100～250ml
  • 250～500ml
  • 500～1000ml
  • 1000毫升以上

第七章 输液袋市场（依腔室类型）

  • 介绍
  • 单室
  • 多室

第 8 章 输液袋市场以最终用户划分

  • 介绍
  • 血库
  • 医院
  • 门诊服务

第九章 输液袋市场区域分布

  • 介绍
  • 北美洲
    • 按类型
    • 按容量
    • 按腔室类型
    • 按最终用户
    • 按国家
  • 南美洲
    • 按类型
    • 按容量
    • 按腔室类型
    • 按最终用户
    • 按国家
  • 欧洲
    • 按类型
    • 按容量
    • 按腔室类型
    • 按最终用户
    • 按国家
  • 中东和非洲
    • 按类型
    • 按容量
    • 按腔室类型
    • 按最终用户
    • 按国家
  • 亚太地区
    • 按类型
    • 按容量
    • 按腔室类型
    • 按最终用户
    • 按国家

第十章 竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 企业合併（M&A）、协议、商业合作
  • 竞争仪錶板

第十一章 公司简介

  • Sippex
  • Kraton Corporation
  • Renolit Solmed
  • Alfa Laboratories
  • Polycine GmbH
  • Haemotronic SPA
  • Hospira Inc.
  • Technoflex SA
  • The Metrix Company
  • Medicopack A/S
  • Wipak Group
  • Qosina Corporation
简介目录
Product Code: KSI061612706

The IV Bags market is projected to grow from US$4.312 billion in 2025 to US$5.677 billion in 2030 at a CAGR of 5.66%.

IV bags are pouches containing fluids, electrolytes, vitamins, minerals, and glucose solutions among others which are used in administering necessary fluids and nutrients in the body. The demand for IV packs is witnessing positive growth fueled by the growing electrolyte depletion, lack of hydration, and malnutrition problems in individuals which has bolstered the need for liquid nutrients and alternatives to be injected into the human body.

Furthermore, IV packs are becoming progressively prevalent and favored alternatives for parenteral bundling due to their simple accessibility. The cost of an IV sack is roughly $1, which significantly contributes to the market's rising deals.

Moreover, car crashes are one of the leading causes of disability and death worldwide, resulting in up to 50 million injuries and 1.3 million fatalities annually. Across the globe, one in every four deaths is related to walking or bicycling, based on the World Health Organization. Fluid administration is therefore required due to the rising number of surgeries and accidents, which is anticipated to spur market expansion.

IV Bags Market Drivers

  • Growing chronic disease prevalence is propelling the market demand.

Factors such as the rising prevalence of chronic diseases, the increased number of surgeries and road accidents, and the growing geriatric population are expected to drive market growth during the forecast period. For instance, according to the National Institute of Health in July 2022 stated that around 20% of individuals in western locales, such as North America and Europe, have gastroesophageal reflux illness (GERD) as of 2022. Besides, the predominance of GERD in the US extended from 18.1% to 27.8%

Furthermore, information from the Cancer Realities and Figures 2023 report demonstrates that 297,790 ladies in the US are expected to get an obtrusive breast cancer conclusion in 2023, up from 287,850 modern cases in 2022. Additionally, the same source states that in 2023, compared to 51,400 cases in 2022, approximately 55,720 women in the US are anticipated to receive a non-invasive (in situ) breast cancer diagnosis. Since cancer treatment deprives the body of nutrition and affects the body by causing ulcers, gastrointestinal dysfunction, and physical blockages, it is anticipated that the demand for IV bags will increase. It increases the need for patients to receive parenteral nutrition, which drives market expansion.

IV Bags Market geographical outlook

  • North America will continue to be the dominant market shareholder during the forecast period.

Geographically, the IV bags market has been segmented into North America, South America, Europe, the Middle East, Africa, and the Asia Pacific.

During the forecast period, the North American region is estimated to hold a considerable market share fueled by the growing chronic disease prevalence in the major regional economies, followed by well-established healthcare infrastructure and an increase in the number of surgical procedures and hospital visits. According to the American Hospital Association, in 2022, the strength of hospitals in the United States stood at 6,129, whereas the total number of admissions in U.S. hospitals reached 34,011,386.

Likewise, the increase in the prevalence of surgical procedures has also propelled the market demand, for instance, according to the American Society of Plastic Surgeons, in 2023, the total number of surgical procedures reported was 1,575,244 which signified a 5% growth over figure reported in 2022. Additionally, as per the data provided by the Alberta government, in 2022, the total number of surgeries conducted stood at 292,500 which represented a 13,900 increase over the preceding year's surgical volume.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The IV Bags Market is analyzed into the following segments:

By Type

  • PVC
  • PP
  • PE

By Capacity

  • Less than 100 ml
  • 100-250 ml
  • 250-500 ml
  • 500-1000 ml
  • Above 1000 ml

By Chamber Type

  • Single Chamber
  • Multi-Chamber

By End-User

  • Blood Banks
  • Hospitals
  • Ambulatory Services

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • Israel
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. CXO Perspective

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. IV BAGS MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. PVC
  • 5.3. PP
  • 5.4. PE

6. IV BAGS MARKET BY CAPACITY

  • 6.1. Introduction
  • 6.2. Less than 100 ml
  • 6.3. 100-250 ml
  • 6.4. 250-500 ml
  • 6.5. 500-1000 ml
  • 6.6. Above 1000 ml

7. IV BAGS MARKET BY CHAMBER TYPE

  • 7.1. Introduction
  • 7.2. Single Chamber
  • 7.3. Multi-Chamber

8. IV BAGS MARKET END-USER

  • 8.1. Introduction
  • 8.2. Blood Banks
  • 8.3. Hospitals
  • 8.4. Ambulatory Services

9. IV BAGS MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. By Type
    • 9.2.2. By Capacity
    • 9.2.3. By Chamber Type
    • 9.2.4. By End-User
    • 9.2.5. By Country
      • 9.2.5.1. USA
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. South America
    • 9.3.1. By Type
    • 9.3.2. By Capacity
    • 9.3.3. By Chamber Type
    • 9.3.4. By End-User
    • 9.3.5. By Country
      • 9.3.5.1. Brazil
      • 9.3.5.2. Argentina
      • 9.3.5.3. Others
  • 9.4. Europe
    • 9.4.1. By Type
    • 9.4.2. By Capacity
    • 9.4.3. By Chamber Type
    • 9.4.4. By End-User
    • 9.4.5. By Country
      • 9.4.5.1. Germany
      • 9.4.5.2. France
      • 9.4.5.3. United Kingdom
      • 9.4.5.4. Spain
      • 9.4.5.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. By Type
    • 9.5.2. By Capacity
    • 9.5.3. By Chamber Type
    • 9.5.4. By End-User
    • 9.5.5. By Country
      • 9.5.5.1. Saudi Arabia
      • 9.5.5.2. Israel
      • 9.5.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. By Type
    • 9.6.2. By Capacity
    • 9.6.3. By Chamber Type
    • 9.6.4. By End-User
    • 9.6.5. By Country
      • 9.6.5.1. China
      • 9.6.5.2. Japan
      • 9.6.5.3. South Korea
      • 9.6.5.4. India
      • 9.6.5.5. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Sippex
  • 11.2. Kraton Corporation
  • 11.3. Renolit Solmed
  • 11.4. Alfa Laboratories
  • 11.5. Polycine GmbH
  • 11.6. Haemotronic S.P.A.
  • 11.7. Hospira Inc.
  • 11.8. Technoflex S.A.
  • 11.9. The Metrix Company
  • 11.10. Medicopack A/S
  • 11.11. Wipak Group
  • 11.12. Qosina Corporation